JP2010533717A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2010533717A5 JP2010533717A5 JP2010517021A JP2010517021A JP2010533717A5 JP 2010533717 A5 JP2010533717 A5 JP 2010533717A5 JP 2010517021 A JP2010517021 A JP 2010517021A JP 2010517021 A JP2010517021 A JP 2010517021A JP 2010533717 A5 JP2010533717 A5 JP 2010533717A5
- Authority
- JP
- Japan
- Prior art keywords
- unsubstituted
- substituted
- pharmaceutical composition
- alkyl
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US96120707P | 2007-07-18 | 2007-07-18 | |
| PCT/US2008/008773 WO2009011901A2 (en) | 2007-07-18 | 2008-07-18 | Methods for promoting wakefulness |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2010533717A JP2010533717A (ja) | 2010-10-28 |
| JP2010533717A5 true JP2010533717A5 (enExample) | 2011-09-01 |
Family
ID=39832375
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010517021A Withdrawn JP2010533717A (ja) | 2007-07-18 | 2008-07-18 | 覚醒を促進する方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20090048229A1 (enExample) |
| EP (1) | EP2182938A2 (enExample) |
| JP (1) | JP2010533717A (enExample) |
| CN (1) | CN101795683A (enExample) |
| AU (1) | AU2008276459A1 (enExample) |
| CA (1) | CA2693110A1 (enExample) |
| WO (1) | WO2009011901A2 (enExample) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2010518010A (ja) | 2007-02-02 | 2010-05-27 | コルシド・ファーマシューティカルズ・インコーポレイテッド | コリンエステラーゼを阻害する化合物 |
| EP2413926A2 (en) * | 2009-04-02 | 2012-02-08 | Colucid Pharmaceuticals, Inc. | Compositions of cholinesterase inhibitors |
| BR112013007040B8 (pt) * | 2010-09-27 | 2022-11-08 | Du Pont | Método para preparar um composto de fórmula 1 |
| CA3123900A1 (en) * | 2011-07-28 | 2013-01-31 | Kempharm Inc. | Methylphenidate-prodrugs, processes of making and using the same |
| ES2545836B1 (es) * | 2014-03-13 | 2016-07-07 | Elaborados Castellano, S.L. | Composición potenciadora de vigilia, y usos de la misma |
| WO2019112007A1 (ja) * | 2017-12-07 | 2019-06-13 | 国立大学法人 筑波大学 | 鎮痛薬による眠気の予防または治療薬 |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3600427A (en) * | 1967-05-08 | 1971-08-17 | Anthony J Verbiscar | Phenyl carbamate latentiated phenethylamines |
| IL74497A (en) * | 1985-03-05 | 1990-02-09 | Proterra Ag | Pharmaceutical compositions containing phenyl carbamate derivatives and certain phenyl carbamate derivatives |
| US4791107A (en) * | 1986-07-16 | 1988-12-13 | Hoechst-Roussel Pharmaceuticals, Inc. | Memory enhancing and analgesic 1,2,3,3A,8,8A-hexahydro-3A,8 (and) 1,3A,8)-di(and tri)methylpyrrolo(2,3-B)indoles, compositions and use |
| NL195004C (nl) * | 1987-03-04 | 2003-11-04 | Novartis Ag | Fenylcarbamaat bevattend farmaceutisch preparaat. |
| US5187165A (en) * | 1987-05-15 | 1993-02-16 | Hoechst-Roussel Pharmaceuticals Inc. | Memory enhancing and analgesic 1,2,3a,8,8a-hexahydro-3a,8(and 1,3a,8)-di(and tri)methylpyrrolo[2,3-b]indoles |
| IT1251166B (it) * | 1991-08-09 | 1995-05-04 | Chiesi Farma Spa | Derivati di geneserina,loro preparazione e composizioni farmaceutiche che li contengono |
| US5302721A (en) * | 1992-07-21 | 1994-04-12 | Hoechst-Roussel Pharmaceuticals Incorporated | Method of preparation of physostigmine carbamate derivatives from eseretholes |
| US5409948A (en) * | 1992-11-23 | 1995-04-25 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Method for treating cognitive disorders with phenserine |
| SE9504537D0 (sv) * | 1995-12-19 | 1995-12-19 | Jan Hedner | Sätt att behandla och diagnosticera andningsstörningar under sömn och medel för utförande av sättet |
| US5665880A (en) * | 1996-10-31 | 1997-09-09 | Hoechst Marion Roussel, Inc. | Method of preparation of physostigmine carbamate derivatives from eseretholes |
| US5677457A (en) * | 1996-12-19 | 1997-10-14 | Hoechst Marion Roussel, Inc. | Method of preparation of physostigmine carbamate derivatives from eseroline ethers |
| AU749088C (en) * | 1997-07-09 | 2005-11-03 | Axonyx, Inc. | Highly selective butyrylcholinesterase inhibitors for the treatment and diagnosis of Alzheimer's disease and dementias |
| SE9803760D0 (sv) * | 1998-11-04 | 1998-11-04 | Jan Hedner | Sätt att behandla och diagnostisera syndromet restless legs och motsvarande medel |
| WO2004034963A2 (en) * | 2002-05-17 | 2004-04-29 | Eisai Co., Ltd. | Methods and compositions using cholinesterase inhibitors |
| US7297691B2 (en) * | 2003-08-13 | 2007-11-20 | Janssen Pharmaceutica N.V. | Treatment of sleep disorders with cholinesterase inhibitors |
| US7795307B2 (en) * | 2003-10-21 | 2010-09-14 | Colucid Pharmaceuticals, Inc. | Carbamoyl esters that inhibit cholinesterase and release pharmacologically active agents |
| JP2010518010A (ja) * | 2007-02-02 | 2010-05-27 | コルシド・ファーマシューティカルズ・インコーポレイテッド | コリンエステラーゼを阻害する化合物 |
| JP2010526820A (ja) * | 2007-05-07 | 2010-08-05 | チェルシー・セラピューティクス，インコーポレイテッド | 気分障害、睡眠障害、または注意欠陥障害を治療するドロキシドパおよびその医薬組成物 |
-
2008
- 2008-07-18 AU AU2008276459A patent/AU2008276459A1/en not_active Abandoned
- 2008-07-18 WO PCT/US2008/008773 patent/WO2009011901A2/en not_active Ceased
- 2008-07-18 CN CN200880105586A patent/CN101795683A/zh active Pending
- 2008-07-18 CA CA2693110A patent/CA2693110A1/en not_active Abandoned
- 2008-07-18 JP JP2010517021A patent/JP2010533717A/ja not_active Withdrawn
- 2008-07-18 US US12/218,813 patent/US20090048229A1/en not_active Abandoned
- 2008-07-18 EP EP08780244A patent/EP2182938A2/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2012505836A5 (enExample) | ||
| JP2010533717A5 (enExample) | ||
| JP2004519469A5 (enExample) | ||
| JP2017531038A5 (enExample) | ||
| JP2013526544A5 (enExample) | ||
| JP2013518107A5 (enExample) | ||
| JP2019526596A5 (enExample) | ||
| JP2009143956A5 (enExample) | ||
| JP2010077141A5 (enExample) | ||
| JP2008514732A5 (enExample) | ||
| RU2005107314A (ru) | Пиримидопроизводные, характеризующиеся антипролиферативной активностью | |
| JP2006143751A5 (enExample) | ||
| JP2014506907A5 (enExample) | ||
| JP2009504763A5 (enExample) | ||
| JP2012255026A5 (enExample) | ||
| JP2013545730A5 (enExample) | ||
| JP2009505980A5 (enExample) | ||
| JP2013508279A5 (enExample) | ||
| JP2012092103A5 (enExample) | ||
| JP2013509392A5 (enExample) | ||
| JP2012506872A5 (enExample) | ||
| JP2014505107A5 (enExample) | ||
| JP2010521417A5 (enExample) | ||
| JP6014142B2 (ja) | Ｎ−ヒドロキシ−４−｛２−［３−（ｎ，ｎ−ジメチルアミノメチル）ベンゾフラン−２−イルカルボニルアミノ］エトキシ｝ベンズアミドの投与に関するスキーム | |
| JP2017525699A5 (enExample) |